West Chester, OH, United States of America

Daniel J Karlik

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Cognis IP Management Gmbh. Active years: 2014.


% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Daniel J. Karlik

Introduction

Daniel J. Karlik is an accomplished inventor based in West Chester, Ohio. He has made significant contributions to the field of biocide compositions, showcasing his expertise through his innovative patent. His work is characterized by a focus on enhancing the effectiveness of biocides through unique chemical compositions.

Latest Patents

Daniel J. Karlik holds a patent for "Biocide compositions comprising glycerol(ether)phosphates." This patent suggests biocide compositions that include (a) glycerol(ether)phosphates, (b) biocides, and optionally (c) oil components or co-solvents and/or (d) emulsifiers. The compositions developed by Karlik demonstrate excellent adjuvant and complexing properties, making them valuable in various applications.

Career Highlights

Karlik is associated with Cognis IP Management GmbH, where he continues to innovate and develop new solutions in the field of biocides. His work has not only contributed to the company's portfolio but has also advanced the understanding of biocide effectiveness in various formulations.

Collaborations

Throughout his career, Daniel has collaborated with notable professionals, including Joaquin Bigorra Llosas and Timothy H. Anderson. These collaborations have enriched his research and development efforts, leading to more robust and effective biocide compositions.

Conclusion

Daniel J. Karlik's contributions to the field of biocide compositions highlight his innovative spirit and dedication to advancing chemical solutions. His patent and ongoing work at Cognis IP Management GmbH reflect his commitment to improving biocide effectiveness through scientific innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…